Akershus University Hospital
Nordbyhagen, Akershus, 1478, Norway
NCT Number: NCT02717637
All patients undergoing an elective caesarean section under spinal anesthesia will, according to the hospital routines, receive 10 mg oxycodone slow-release tablet when arriving at our postoperative care unit (PACU). Blood samples will be taken at 0 hour, 1 hour, 2 and 6 hours after administration in order to investigate bioavailability.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Nordbyhagen, Akershus, 1478, Norway
After written informed consent, blood samples will be taken before administration, after 1 hour, 2 hours and 6 hours. Need of rescue analgesia (morphine iv) and level of pain, as well as side effects will be registered
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy women > 18 years old, with one healthy fetus scheduled for a elective caesarean section in spinal anesthesia, read and signed informed consent
-
Exclusion criteria
Time frame: 1 hour after administration
Time frame: 2 hours after administration
Time frame: 6 hours after administration
Time frame: 0, 1, 2, and 6 hours after administration
NRS scale 0-10
Time frame: 1,2 and 6 hourd after administration
nausea and vomiting, other side effects
University Hospital, Akershus
Other
Gastrointestinal Uptake of Oxycodone After Caesarean Section in Spinal Anesthesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05575700
Acute Pain, Agnosia
Brøndby, Denmark
View Trial DetailsNCT04369222
Analgesic Adverse Reaction, Gonad Regulating Hormone Adverse Reaction
Copenhagen, Denmark
View Trial DetailsNCT05924412
Acute Pain, Agnosia
Santiago, Metropolitan, Chile
View Trial DetailsNCT05880433
Analgesic Adverse Reaction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Istanbul, Turkey (Türkiye)
View Trial Details